-
1. Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma. An Analysis of 1000 Cases. Cancer 2005;103(6): 1201-9.
Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M.
-
2. Proposal of a New Prognostic Model for Hepatocellular Carcinoma: An Analysis of 403 Patients. Gut 2005;54(3): 419-25.
Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Makuuchi M, Omata M.
-
3. Prediction of Recurrence of Hepatocellular Carcinoma after Curative Ablation Using Three Tumor Markers. Hepatology 2006;44(6): 1518-27.
Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M.
-
4. Radiofrequency Ablation for Hepatocellular Carcinoma in So-Called High-Risk Locations. Hepatology 2006;43(5): 1101-8.
Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M.
-
5. Neoplastic Seeding after Radiofrequency Ablation for Hepatocellular Carcinoma. Am J Gastroenterol 2008;103(12): 3057-62.
Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Yoshida H, Omata M.
-
6. Obesity Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients. Clin Gastroenterol Hepatol 2008;6(4): 459-64.
Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, Yamashiki N, Yoshida H, Kanai F, Kato N, Shiina S, Yoshida H, Kawabe T, Omata M.
-
7. Prospective Risk Assessment for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C by Transient Elastography. Hepatology 2009;49(6): 1954-61.
Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, Imamura J, Goto T, Kanai F, Kato N, Ikeda H, Shiina S, Kawabe T, Omata M.
-
8. Visceral Fat Accumulation Is an Independent Risk Factor for Hepatocellular Carcinoma Recurrence after Curative Treatment in Patients with Suspected Nash. Gut 2009;58(6): 839-44.
Ohki T, Tateishi R, Shiina S, Goto E, Sato T, Nakagawa H, Masuzaki R, Goto T, Hamamura K, Kanai F, Yoshida H, Kawabe T, Omata M.
-
9. Genome-Wide Association Study Identifies a Susceptibility Locus for Hcv-Induced Hepatocellular Carcinoma. Nat Genet 2011;43(5): 455-8.
Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R, Hosono N, Otsuka M, Tateishi R, Omata M, Nakagawa H, Koike K, Kamatani N, Kubo M, Nakamura Y, Matsuda K.
-
10. Increased Activity of Serum Mitochondrial Isoenzyme of Creatine Kinase in Hepatocellular Carcinoma Patients Predominantly with Recurrence. J Hepatol 2012;57(2): 330-6.
Soroida Y, Ohkawa R, Nakagawa H, Satoh Y, Yoshida H, Kinoshita H, Tateishi R, Masuzaki R, Enooku K, Shiina S, Sato T, Obi S, Hoshino T, Nagatomo R, Okubo S, Yokota H, Koike K, Yatomi Y, Ikeda H.
-
11. Hepatocellular Carcinoma in 2011: Genomics in Hepatocellular Carcinoma--a Big Step Forward. Nat Rev Gastroenterol Hepatol 2012;9(2): 69-70.
Tateishi R, Omata M.
-
12. Ct with Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial. Am J Gastroenterol 2013;108(8): 1305-13.
Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Matsuyama Y, Omata M, Ohtomo K, Koike K.
-
13. A Genome-Wide Association Study of Hcv-Induced Liver Cirrhosis in the Japanese Population Identifies Novel Susceptibility Loci at the Mhc Region. J Hepatol 2013;58(5): 875-82.
Urabe Y, Ochi H, Kato N, Kumar V, Takahashi A, Muroyama R, Hosono N, Otsuka M, Tateishi R, Lo PH, Tanikawa C, Omata M, Koike K, Miki D, Abe H, Kamatani N, Toyota J, Kumada H, Kubo M, Chayama K, Nakamura Y, Matsuda K.
-
14. Drastically Reduced Neoplastic Seeding Related to Radiofrequency Ablation for Hepatocellular Carcinoma. Am J Gastroenterol 2014;109(5): 774-6.
Nakagomi R, Tateishi R, Shiina S, Imamura J, Fujiwara N, Asaoka Y, Kondo Y, Koike K.
-
15. Sarcopenia, Intramuscular Fat Deposition, and Visceral Adiposity Independently Predict the Outcomes of Hepatocellular Carcinoma. J Hepatol 2015;63(1): 131-40.
Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami T, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Tanaka Y, Ohtomo K, Shiina S, Koike K.
-
16. Clinical Characteristics, Treatment, and Prognosis of Non-B, Non-C Hepatocellular Carcinoma: A Large Retrospective Multicenter Cohort Study. J Gastroenterol 2015;50(3): 350-60.
Tateishi R, Okanoue T, Fujiwara N, Okita K, Kiyosawa K, Omata M, Kumada H, Hayashi N, Koike K.
-
17. The Impact of Direct-Acting Antivirals on Early Tumor Recurrence after Radiofrequency Ablation in Hepatitis C-Related Hepatocellular Carcinoma. J Hepatol 2016;65(6): 1272-73.
Minami T, Tateishi R, Nakagomi R, Fujiwara N, Sato M, Enooku K, Nakagawa H, Asaoka Y, Kondo Y, Shiina S, Koike K.
-
18. Cpt2 Downregulation Adapts Hcc to Lipid-Rich Environment and Promotes Carcinogenesis Via Acylcarnitine Accumulation in Obesity. Gut 2018;67(8): 1493-504.
Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, Tanaka Y, Tateishi R, Hikiba Y, Misumi K, Tanaka M, Hayashi A, Shibahara J, Fukayama M, Arita J, Hasegawa K, Hirschfield H, Hoshida Y, Hirata Y, Otsuka M, Tateishi K, Koike K.
-
19. Impact of Direct-Acting Antivirals on Early Recurrence of Hcv-Related Hcc: Comparison with Interferon-Based Therapy. J Hepatol 2019;70(1): 78-86.
Nishibatake Kinoshita M, Minami T, Tateishi R, Wake T, Nakagomi R, Fujiwara N, Sato M, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Shiina S, Koike K.
-
20. Hepatic Sdf2l1 Controls Feeding-Induced Er Stress and Regulates Metabolism. Nat Commun 2019;10(1): 947.
Sasako T, Ohsugi M, Kubota N, Itoh S, Okazaki Y, Terai A, Kubota T, Yamashita S, Nakatsukasa K, Kamura T, Iwayama K, Tokuyama K, Kiyonari H, Furuta Y, Shibahara J, Fukayama M, Enooku K, Okushin K, Tsutsumi T, Tateishi R, Tobe K, Asahara H, Koike K, Kadowaki T, Ueki K.
-
21. A Nationwide Survey on Non-B, Non-C Hepatocellular Carcinoma in Japan: 2011-2015 Update. J Gastroenterol 2019;54(4): 367-76.
Tateishi R, Uchino K, Fujiwara N, Takehara T, Okanoue T, Seike M, Yoshiji H, Yatsuhashi H, Shimizu M, Torimura T, Moriyama M, Sakaida I, Okada H, Chiba T, Chuma M, Nakao K, Isomoto H, Sasaki Y, Kaneko S, Masaki T, Chayama K, Koike K.
-
22. Orchestration of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Ubiquitous Cellular Protein Tctp Released by Tumor Cells. Nat Immunol 2021;22(8): 947-57.
Hangai S, Kawamura T, Kimura Y, Chang CY, Hibino S, Yamamoto D, Nakai Y, Tateishi R, Oshima M, Oshima H, Kodama T, Moriya K, Koike K, Yanai H, Taniguchi T.
-
23. Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after Hcv Eradication with Antivirals. Liver Cancer 2021;10(4): 309-19.
Minami T, Tateishi R, Fujiwara N, Nakagomi R, Nakatsuka T, Sato M, Uchino K, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Hanajiri K, Asaoka Y, Kondo Y, Tanaka Y, Otsuka M, Ohki T, Arai M, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Koike Y, Akamatsu M, Mitsui H, Fujie H, Ogura K, Yoshida H, Wada T, Kurai K, Maekawa H, Obi S, Teratani T, Masaki N, Nagashima K, Ishikawa T, Kato N, Moriya K, Yotsuyanagi H, Koike K.
-
24. Hepatocellular Carcinoma Development in Diabetic Patients: A Nationwide Survey in Japan. J Gastroenterol 2021;56(3): 261-73.
Tateishi R, Matsumura T, Okanoue T, Shima T, Uchino K, Fujiwara N, Senokuchi T, Kon K, Sasako T, Taniai M, Kawaguchi T, Inoue H, Watada H, Kubota N, Shimano H, Kaneko S, Hashimoto E, Watanabe S, Shiota G, Ueki K, Kashiwabara K, Matsuyama Y, Tanaka H, Kasuga M, Araki E, Koike K, investigators Ls.
-
25. Risk Stratification of Hepatocellular Carcinoma after Hepatitis C Virus Eradication in Patients with Compensated Advanced Chronic Liver Disease in Japan. J Hepatol 2022;77(2): 569-71.
Nakatsuka T, Tateishi R, Nakagomi R, Minami T, Koike K.
-
26. Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy: An Individual Patient Data Meta-Analysis. Gut 2022;71(3): 593-604.
Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Marino Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, Singal AG, Murphy C, Kohla M, Masetti C, Dufour JF, Merchante N, Cavalletto L, Chemello LL, Pol S, Crespo J, Calleja JL, Villani R, Serviddio G, Zanetto A, Shalaby S, Russo FP, Bielen R, Trevisani F, Camma C, Bruix J, Cabibbo G, Reig M.
-
27. Surgery Versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (Surf Trial). Liver Cancer 2022;11(3): 209-18.
Takayama T, Hasegawa K, Izumi N, Kudo M, Shimada M, Yamanaka N, Inomata M, Kaneko S, Nakayama H, Kawaguchi Y, Kashiwabara K, Tateishi R, Shiina S, Koike K, Matsuyama Y, Omata M, Makuuchi M, Kokudo N.
-
28. Agile Scores Are a Good Predictor of Liver-Related Events in Patients with Nafld. J Hepatol 2023.
Nakatsuka T, Tateishi R, Sato M, Fujishiro M, Koike K.
-
29. Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The Nash App Clinical Trial. Am J Gastroenterol 2023.
Sato M, Akamatsu M, Shima T, Ikegami T, Yanase M, Mikami S, Imamura J, Nakatsuka T, Tateishi R, Yamauchi N, Ushiku T, Okanoue T, Fujishiro M, Hida E, Koike K.
-
他190篇
